1 completed, 1 not yet recruiting, 1 unknown. 2 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Amyloid Precursor Protein Secretases: new trials by email Literature Review of Amyloid Precursor Protein Secretases trials Research Report on Amyloid Precursor Protein Secretases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat Nirogacestat, Nirogacestat and Famotidine, Nirogacestat and Rabeprazole - Healthy | Phase 1 | Completed | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 24 | 2025-08-21 | 2026-05-08 |
| Application-Assisted Weight Management in Endometrial Cancer Fertility Preservation DEAR weight management, Standardized discharge care plan and follow-up schedule, Implementation of the weight management mobile health application - Endometrial Cancer, Mobile Applications | Not applicable | Not yet recruiting | Peking University People's Hospital | 106 | 2025-03-31 | 2025-04-03 |
| Comparison of Mindfulness Meditation Tools For College Students Apps, EEG neurofeedback - Stress, Anxiety | Not applicable | Unknown | University of Connecticut | 140 | 2018-03-05 | 2019-09-26 |
Anxiety Disorders (1) · Endometrial Neoplasms (1) · Weight Loss (1)
Peking University People's Hospital (1) · SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany (1) · University of Connecticut (1)
United States (2) · China (1)
Blair T. Johnson, PhD (1) · Mary Beth Brune, MD (1) · Xiaodan Li (1)